There are multiple big-time, primary care deals on the horizon. 

And the names tied to those deals are behemoths in size and influence. They are also tied heavily to the home-based care space.

This week, stocks were jumpy for Cano Health Inc. (NYSE: CANO) and 1Life Healthcare Inc. (Nasdaq: ONEM), the parent company of One Medical.

Reportedly, Cano Health could be the next acquisition target for Humana Inc. (NYSE: HUM), which has been building out its risk-based capabilities through primary care purchases, the expansion of its CenterWell clinics and, of course, the Kindred at Home takeover, over the past few years. Cano Health’s stock had jumped by nearly 30% over the past five days as of Thursday morning.

Dealreporter called a Cano Health deal a more “readily accessible option” for Humana given right of first refusal stipulations. Cano Health is a senior primary care company with 137 medical centers in six states. Humana has rapidly been building out its senior primary care footprint via a joint venture with the private equity firm Welsh, Carson, Anderson & Stowe (WCAS).